NEW YORK (GenomeWeb) – Genedata said this week that GlaxoSmithKline's biopharma research and development arm has selected its Genedata Biologics software to handle data management and workflow support needs.
The Genedata Biologics platform will support multiple groups within GSK including teams working on lead identification and screening, protein optimization and engineering, and protein production. GSK will use the system to record, manage, share, and process data from its antibody discovery platforms, including its phage and yeast display, hybridoma, and other technologies.
Financial and other terms of the licensing agreement were not disclosed.